Astrid Berger

639 total citations
19 papers, 354 citations indexed

About

Astrid Berger is a scholar working on Oncology, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Astrid Berger has authored 19 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Reproductive Medicine and 5 papers in Molecular Biology. Recurrent topics in Astrid Berger's work include Ovarian cancer diagnosis and treatment (7 papers), Cancer-related Molecular Pathways (7 papers) and Cancer Genomics and Diagnostics (3 papers). Astrid Berger is often cited by papers focused on Ovarian cancer diagnosis and treatment (7 papers), Cancer-related Molecular Pathways (7 papers) and Cancer Genomics and Diagnostics (3 papers). Astrid Berger collaborates with scholars based in Austria, United States and Germany. Astrid Berger's co-authors include Robert Zeillinger, J. Petres, Christian Marth, Alain G. Zeimet, Gerda Hofstetter, Nicole Concin, Daniel Reimer, Ute M. Moll, Elena Ioana Braicu and Heidi Fiegl and has published in prestigious journals such as Oncogene, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Astrid Berger

18 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Astrid Berger Austria 10 212 207 97 54 32 19 354
Monica Valenti Italy 8 238 1.1× 227 1.1× 56 0.6× 35 0.6× 37 1.2× 17 348
Yongrui Du China 9 133 0.6× 105 0.5× 58 0.6× 11 0.2× 94 2.9× 16 354
Esther M. Hoogervorst Netherlands 10 282 1.3× 195 0.9× 103 1.1× 51 0.9× 5 0.2× 12 367
Chenyi Zhou China 11 196 0.9× 95 0.5× 71 0.7× 14 0.3× 27 0.8× 20 299
Vilhelm A. Bohr United States 8 421 2.0× 185 0.9× 145 1.5× 9 0.2× 34 1.1× 11 538
Landon G. Piluso United States 7 436 2.1× 220 1.1× 63 0.6× 23 0.4× 3 0.1× 7 521
Chiara Bellio United States 8 345 1.6× 192 0.9× 245 2.5× 15 0.3× 43 1.3× 10 467
Olga Collins Canada 14 185 0.9× 131 0.6× 60 0.6× 13 0.2× 106 3.3× 17 431
W‐C Hung Taiwan 9 302 1.4× 99 0.5× 148 1.5× 9 0.2× 4 0.1× 9 434
Rachel Amado Bortnick United States 3 332 1.6× 194 0.9× 71 0.7× 43 0.8× 4 0.1× 3 401

Countries citing papers authored by Astrid Berger

Since Specialization
Citations

This map shows the geographic impact of Astrid Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Astrid Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Astrid Berger more than expected).

Fields of papers citing papers by Astrid Berger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Astrid Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Astrid Berger. The network helps show where Astrid Berger may publish in the future.

Co-authorship network of co-authors of Astrid Berger

This figure shows the co-authorship network connecting the top 25 collaborators of Astrid Berger. A scholar is included among the top collaborators of Astrid Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Astrid Berger. Astrid Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Berger, Astrid, Elisabeth Pechriggl, Heidi Fiegl, et al.. (2022). A comparison of four technologies for detecting p53 aggregates in ovarian cancer. Frontiers in Oncology. 12. 976725–976725. 1 indexed citations
2.
Azim, Samira Abdel, Katharina Leitner, Astrid Berger, et al.. (2021). Screening for Open Spina Bifida in a Routine Clinical Setting at the First-Trimester Scan: A Prospective Multicentre Cohort Study. Fetal Diagnosis and Therapy. 48(2). 96–102. 3 indexed citations
3.
Azim, Samira Abdel, Irene Mutz‐Dehbalaie, Verena Wieser, et al.. (2021). Influence of Pregnancy-Related Conditions on Human Epididymis Protein 4 Serum Levels in Comparison to CA 125 – a Prospective Cohort Trial. Geburtshilfe und Frauenheilkunde. 81(9). 1047–1054.
4.
Berger, Astrid, et al.. (2020). Uterine torsion in pregnancy. Archives of Gynecology and Obstetrics. 302(4). 791–792. 1 indexed citations
5.
Canazei, Markus, Harald R. Bliem, Elisabeth M. Weiss, et al.. (2019). Effects of adjustable dynamic bedroom lighting in a maternity ward. Journal of Environmental Psychology. 62. 59–66. 9 indexed citations
6.
Seebacher, Veronika, Stephan Polterauer, Alexander Reinthaller, et al.. (2018). AB0 blood groups and rhesus factor expression as prognostic parameters in patients with epithelial ovarian cancer – a retrospective multi-centre study. BMC Cancer. 18(1). 447–447. 3 indexed citations
7.
Aust, Stefanie, Anna Bachmayr-Heyda, Dietmar Pils, et al.. (2013). Determination of Tumor-infiltrating CD8+ Lymphocytes in Human Ovarian Cancer. International Journal of Gynecological Pathology. 32(3). 269–276. 10 indexed citations
8.
Pils, Dietmar, Anna Bachmayr-Heyda, Katharina Auer, et al.. (2013). Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients – A study of the OVCAD consortium. European Journal of Cancer. 50(1). 99–110. 50 indexed citations
9.
Hofstetter, Gerda, Astrid Berger, Regina Berger, et al.. (2012). The N-Terminally Truncated p53 Isoform △40p53 Influences Prognosis in Mucinous Ovarian Cancer. International Journal of Gynecological Cancer. 22(3). 372–379. 38 indexed citations
10.
Hofstetter, Gerda, Astrid Berger, Elisabeth Müller‐Holzner, et al.. (2011). Clinical Relevance of TAp73 and ΔNp73 Protein Expression in Ovarian Cancer. International Journal of Gynecological Pathology. 30(6). 527–531. 9 indexed citations
11.
Hofstetter, Gerda, Astrid Berger, E. Schuster, et al.. (2011). Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer. British Journal of Cancer. 105(10). 1593–1599. 37 indexed citations
12.
Hofstetter, Gerda, Astrid Berger, Heidi Fiegl, et al.. (2010). Alternative splicing of p53 and p73: the novel p53 splice variant p53δ is an independent prognostic marker in ovarian cancer. Oncogene. 29(13). 1997–2004. 67 indexed citations
13.
Berger, Astrid & Alfred Hobisch. (2008). Treatment options in localised and metastatic renal cell carcinoma. memo - Magazine of European Medical Oncology. 1(3). 167–170. 2 indexed citations
14.
Frauscher, Ferdinand, Leo Pallwein, Andrea Klauser, et al.. (2005). Ultraschallkontrastmittel und Prostatakarzinom. Der Radiologe. 45(6). 544–551. 10 indexed citations
15.
Concin, Nicole, Gerda Hofstetter, Astrid Berger, et al.. (2005). Clinical Relevance of Dominant-Negative p73 Isoforms for Responsiveness to Chemotherapy and Survival in Ovarian Cancer: Evidence for a Crucial p53-p73 Cross-talk In vivo. Clinical Cancer Research. 11(23). 8372–8383. 72 indexed citations
16.
Concin, Nicole, Gerda Hofstetter, Astrid Berger, et al.. (2005). 00054: CLINICAL RELEVANCE OF DOMINANT-NEGATIVE P73 ISOFORMS FOR RESPONSIVENESS TO CHEMOTHERAPY AND SURVIVAL IN OVARIAN CANCER - EVIDENCE FOR A CRUCIAL P53-P73 CROSS-TALK IN VIVO. International Journal of Gynecological Cancer. 15. 66–66. 4 indexed citations
17.
Tal, Yuval, et al.. (1980). Intestinal obstruction caused by primary adhesions due to familial mediterranean fever. Journal of Pediatric Surgery. 15(2). 186–187. 3 indexed citations
18.
Petres, J. & Astrid Berger. (1972). [The effect of inorganic arsenic on DNA-synthesis of human lymphocytes in vitro].. PubMed. 242(4). 343–52. 11 indexed citations
19.
Petres, J. & Astrid Berger. (1972). Zum Einflu� anorganischen Arsens auf die DNS-Synthese menschlicher Lymphocyten in vitro. Archives of Dermatological Research. 242(4). 343–352. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monica Valenti Breakdown of academic impact, for papers by Yongrui Du Breakdown of academic impact, for papers by Esther M. Hoogervorst Breakdown of academic impact, for papers by Chenyi Zhou Breakdown of academic impact, for papers by Vilhelm A. Bohr Breakdown of academic impact, for papers by Landon G. Piluso Breakdown of academic impact, for papers by Chiara Bellio Breakdown of academic impact, for papers by Olga Collins Breakdown of academic impact, for papers by W‐C Hung Breakdown of academic impact, for papers by Rachel Amado Bortnick
Rankless by CCL
2026